Your browser doesn't support javascript.
loading
Prediction of overall survival in patients with Stage I esophageal cancer: A novel web-based calculator.
Yang, Zhuoxin; Yang, Fengwu; Yang, Miaofang; Qi, Ying; Jiang, Mingzuo; Xuan, Ji; Liu, Yu; Tao, Hui; Liu, Yuxiu; Wang, Fangyu.
Affiliation
  • Yang Z; Department of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Yang F; Department of Laboratory Medicine, Shandong Guoxin Healthcare Group Zibo Hospital, Zibo, China.
  • Yang M; Department of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Qi Y; Department of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Jiang M; Department of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Xuan J; Department of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Liu Y; Department of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Tao H; Department of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Liu Y; Data and Statistics Unit of Department of Critical Care Medicine, Jinling Hospital, Nanjing Medical University, Nanjing, China.
  • Wang F; Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.
J Surg Oncol ; 124(5): 767-779, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34263466
ABSTRACT
BACKGROUND AND

AIMS:

In this study, we aimed to develop a convenient web-based calculator to predict the overall survival (OS) of patients with Stage I esophageal cancer (EC).

METHODS:

Data of 1664 patients, between 2004 and 2015, were extracted from the Surveillance, Epidemiology, and End Results database. Least absolute shrinkage and selection operator regression was employed to sift variables; subsequently, Cox proportional hazards regression model was built. We applied the enhanced bootstrap validation to appraise the discrimination and calibration of the model. Clinical benefit was measured using decision curve analysis (DCA). Thereafter, a web-based calculator based on the model, which could be used to predict the 1-, 3-, and 5-year OS rates, was developed.

RESULTS:

Race, age, histologic type, grade, N stage, and therapeutic methods were selected. C-indices of the prediction model in the training and validation groups were 0.726 (95% confidence interval [CI], 0.679-0.773) and 0.724 (95% CI, 0.679-0.769), respectively. Calibration curves showed good agreement between the groups. The DCA demonstrated that the prediction model is clinically useful.

CONCLUSIONS:

The prediction model we developed showed a good performance in calculating the OS rates in patients with Stage I EC. The web-based calculator is available at https//championship.shinyapps.io/dynnomapp/.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Internet / Nomograms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Surg Oncol Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Internet / Nomograms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Surg Oncol Year: 2021 Document type: Article Affiliation country: